Clearstead Advisors, LLC Ocular Therapeutix, Inc Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 35 shares of OCUL stock, worth $386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35Holding current value
$386% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OCUL
# of Institutions
209Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$158 Million4.71% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$141 Million23.46% of portfolio
-
Summer Road LLC West Palm Beach, FL12.6MShares$139 Million98.91% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$127 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$101 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $850M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...